Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 72


A phase 1b randomized, placebo-controlled clinical trial with SNF472 in haemodialysis patients.

Salcedo C, Joubert PH, Ferrer MD, Canals AZ, Maduell F, Torregrosa V, Campistol JM, Ojeda R, Perelló J.

Br J Clin Pharmacol. 2019 Apr;85(4):796-806. doi: 10.1111/bcp.13863. Epub 2019 Feb 19.


Effects of Millimolar Steady-State Hydrogen Peroxide Exposure on Inflammatory and Redox Gene Expression in Immune Cells from Humans with Metabolic Syndrome.

Busquets-Cortés C, Capó X, Argelich E, Ferrer MD, Mateos D, Bouzas C, Abbate M, Tur JA, Sureda A, Pons A.

Nutrients. 2018 Dec 5;10(12). pii: E1920. doi: 10.3390/nu10121920.


Regular Practice of Moderate Physical Activity by Older Adults Ameliorates Their Anti-Inflammatory Status.

Ferrer MD, Capó X, Martorell M, Busquets-Cortés C, Bouzas C, Carreres S, Mateos D, Sureda A, Tur JA, Pons A.

Nutrients. 2018 Nov 16;10(11). pii: E1780. doi: 10.3390/nu10111780.


Peripheral Blood Mononuclear Cells Antioxidant Adaptations to Regular Physical Activity in Elderly People.

Busquets-Cortés C, Capó X, Bibiloni MDM, Martorell M, Ferrer MD, Argelich E, Bouzas C, Carreres S, Tur JA, Pons A, Sureda A.

Nutrients. 2018 Oct 20;10(10). pii: E1555. doi: 10.3390/nu10101555.


First-time-in-human randomized clinical trial in healthy volunteers and haemodialysis patients with SNF472, a novel inhibitor of vascular calcification.

Perelló J, Joubert PH, Ferrer MD, Canals AZ, Sinha S, Salcedo C.

Br J Clin Pharmacol. 2018 Dec;84(12):2867-2876. doi: 10.1111/bcp.13752. Epub 2018 Oct 3.


Cyclooxygenase-2 inhibitors as a therapeutic target in inflammatory diseases.

Ferrer MD, Busquests-Cortes C, Capo X, Tejada S, Tur JA, Pons A, Sureda A.

Curr Med Chem. 2018 May 13. doi: 10.2174/0929867325666180514112124. [Epub ahead of print]


Characterization of SNF472 pharmacokinetics and efficacy in uremic and non-uremic rats models of cardiovascular calcification.

Ferrer MD, Ketteler M, Tur F, Tur E, Isern B, Salcedo C, Joubert PH, Behets GJ, Neven E, D'Haese PC, Perelló J.

PLoS One. 2018 May 9;13(5):e0197061. doi: 10.1371/journal.pone.0197061. eCollection 2018.


Inhibition of Oral Pathogens Adhesion to Human Gingival Fibroblasts by Wine Polyphenols Alone and in Combination with an Oral Probiotic.

Esteban-Fernández A, Zorraquín-Peña I, Ferrer MD, Mira A, Bartolomé B, González de Llano D, Moreno-Arribas MV.

J Agric Food Chem. 2018 Mar 7;66(9):2071-2082. doi: 10.1021/acs.jafc.7b05466. Epub 2018 Feb 21.


Inhibition of Steptococcus mutans biofilm formation by extracts of Tenacibaculum sp. 20J, a bacterium with wide-spectrum quorum quenching activity.

Muras A, Mayer C, Romero M, Camino T, Ferrer MD, Mira A, Otero A.

J Oral Microbiol. 2018 Jan 30;10(1):1429788. doi: 10.1080/20002297.2018.1429788. eCollection 2018.


SNF472, a novel inhibitor of vascular calcification, could be administered during hemodialysis to attain potentially therapeutic phytate levels.

Perelló J, Gómez M, Ferrer MD, Rodríguez NY, Salcedo C, Buades JM, Pérez MM, Torregrosa JV, Martín E, Maduell F.

J Nephrol. 2018 Apr;31(2):287-296. doi: 10.1007/s40620-018-0471-9. Epub 2018 Jan 19.


A novel pharmacodynamic assay to evaluate the effects of crystallization inhibitors on calcium phosphate crystallization in human plasma.

Ferrer MD, Pérez MM, Cànaves MM, Buades JM, Salcedo C, Perelló J.

Sci Rep. 2017 Jul 31;7(1):6858. doi: 10.1038/s41598-017-07203-x.


Health-Associated Niche Inhabitants as Oral Probiotics: The Case of Streptococcus dentisani.

López-López A, Camelo-Castillo A, Ferrer MD, Simon-Soro Á, Mira A.

Front Microbiol. 2017 Mar 10;8:379. doi: 10.3389/fmicb.2017.00379. eCollection 2017.


Effect of antibiotics on biofilm inhibition and induction measured by real-time cell analysis.

Ferrer MD, Rodriguez JC, Álvarez L, Artacho A, Royo G, Mira A.

J Appl Microbiol. 2017 Mar;122(3):640-650. doi: 10.1111/jam.13368.


Haem Biosynthesis and Antioxidant Enzymes in Circulating Cells of Acute Intermittent Porphyria Patients.

Ferrer MD, Mestre-Alfaro A, Martínez-Tomé M, Carrera-Quintanar L, Capó X, Jiménez-Monreal AM, García-Diz L, Roche E, Murcia MA, Tur JA, Pons A.

PLoS One. 2016 Oct 27;11(10):e0164857. doi: 10.1371/journal.pone.0164857. eCollection 2016.


Oral Biofilm Architecture at the Microbial Scale.

Ferrer MD, Mira A.

Trends Microbiol. 2016 Apr;24(4):246-248. doi: 10.1016/j.tim.2016.02.013. Epub 2016 Mar 5.


Association of antidepressant treatment with emergency admission to medical units for patients 65 years or older.

Ortuño N, Cobo J, González E, García I, Ferrer MD, Campos C, Planet N, Oliva JC, Suárez M, Iglesias-Lepine ML, García-Parés G.

Rev Psiquiatr Salud Ment. 2016 Oct - Dec;9(4):210-218. doi: 10.1016/j.rpsm.2015.01.004. Epub 2015 Mar 4. English, Spanish.


Predicting the Development of Tuberculosis with the Tuberculin Skin Test and QuantiFERON Testing.

Altet N, Dominguez J, Souza-Galvão ML, Jiménez-Fuentes MÁ, Milà C, Solsona J, Soriano-Arandés A, Latorre I, Lara E, Cantos A, Ferrer MD, Orcau À, Ruiz-Manzano J, Caylà J.

Ann Am Thorac Soc. 2015 May;12(5):680-8. doi: 10.1513/AnnalsATS.201408-394OC.


Human milk composition differs in healthy mothers and mothers with celiac disease.

Olivares M, Albrecht S, De Palma G, Ferrer MD, Castillejo G, Schols HA, Sanz Y.

Eur J Nutr. 2015 Feb;54(1):119-28. doi: 10.1007/s00394-014-0692-1. Epub 2014 Apr 4.


Antioxidants restore protoporphyrinogen oxidase in variegate porphyria patients.

Ferrer MD, Tauler P, Sureda A, Palacín C, Tur JA, Pons A.

Eur J Clin Invest. 2013 Jul;43(7):668-78. doi: 10.1111/eci.12091. Epub 2013 Apr 20.


Prevalence of verotoxigenic Escherichia coli O157 (VTEC O157) and compliance with microbiological safety standards in bovine carcasses from an industrial beef slaughter plant.

Ramoneda M, Foncuberta M, Simón M, Sabaté S, Ferrer MD, Herrera S, Landa B, Musté N, Martí R, Trabado V, Carbonell O, Vila M, Espelt M, Ramírez B, Durán J.

Lett Appl Microbiol. 2013 Jun;56(6):408-13. doi: 10.1111/lam.12062. Epub 2013 Mar 20.

Supplemental Content

Loading ...
Support Center